X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
aged (1) 1
angioplasty, balloon, coronary - adverse effects (1) 1
angioplasty, balloon, coronary - instrumentation (1) 1
angioplasty, balloon, coronary - mortality (1) 1
antiplatelet therapy (1) 1
asia - epidemiology (1) 1
aspirin - administration & dosage (1) 1
bioabsorbable polymer (1) 1
biodegradable polymer (1) 1
cardiac & cardiovascular systems (1) 1
cardiovascular agents - administration & dosage (1) 1
coated materials, biocompatible (1) 1
coronary angiography (1) 1
coronary artery disease - diagnostic imaging (1) 1
coronary artery disease - mortality (1) 1
coronary artery disease - therapy (1) 1
coronary heart disease (1) 1
coronary restenosis - diagnostic imaging (1) 1
coronary restenosis - etiology (1) 1
coronary restenosis - prevention & control (1) 1
coronary-arteries (1) 1
drug administration schedule (1) 1
drug therapy, combination (1) 1
drug-eluting stents (1) 1
female (1) 1
follow-up (1) 1
humans (1) 1
implantation (1) 1
index medicus (1) 1
kaplan-meier estimate (1) 1
lesions (1) 1
male (1) 1
middle aged (1) 1
platelet aggregation inhibitors - administration & dosage (1) 1
polymers - chemistry (1) 1
product surveillance, postmarketing (1) 1
prospective studies (1) 1
prosthesis design (1) 1
registries (1) 1
registry (1) 1
revascularization (1) 1
risk assessment (1) 1
sirolimus (1) 1
sirolimus - administration & dosage (1) 1
thrombosis (1) 1
thrombosis - diagnostic imaging (1) 1
thrombosis - etiology (1) 1
thrombosis - prevention & control (1) 1
ticlopidine - administration & dosage (1) 1
ticlopidine - analogs & derivatives (1) 1
time factors (1) 1
treatment outcome (1) 1
trial (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


JACC: Cardiovascular Interventions, ISSN 1936-8798, 04/2009, Volume 2, Issue 4, pp. 303 - 309
Objectives: This study sought to evaluate the safety and efficacy of a biodegradable polymer-coated sirolimus-eluting stent (Excel, JW Medical System, Weihai,... 
coronary heart disease | drug-eluting stents | biodegradable polymer | sirolimus | REVASCULARIZATION | CARDIAC & CARDIOVASCULAR SYSTEMS | THROMBOSIS | FOLLOW-UP | CORONARY-ARTERIES | ANTIPLATELET THERAPY | LESIONS | TRIAL | IMPLANTATION | BIOABSORBABLE POLYMER | REGISTRY | Angioplasty, Balloon, Coronary - instrumentation | Prospective Studies | Humans | Middle Aged | Male | Prosthesis Design | Aspirin - administration & dosage | Thrombosis - diagnostic imaging | Angioplasty, Balloon, Coronary - adverse effects | Angioplasty, Balloon, Coronary - mortality | Time Factors | Platelet Aggregation Inhibitors - administration & dosage | Product Surveillance, Postmarketing | Ticlopidine - administration & dosage | Female | Registries | Thrombosis - prevention & control | Drug Therapy, Combination | Coronary Restenosis - etiology | Cardiovascular Agents - administration & dosage | Drug-Eluting Stents | Drug Administration Schedule | Risk Assessment | Kaplan-Meier Estimate | Coronary Restenosis - prevention & control | Treatment Outcome | Coated Materials, Biocompatible | Coronary Artery Disease - mortality | Coronary Restenosis - diagnostic imaging | Ticlopidine - analogs & derivatives | Coronary Angiography | Sirolimus - administration & dosage | Asia - epidemiology | Coronary Artery Disease - diagnostic imaging | Coronary Artery Disease - therapy | Thrombosis - etiology | Polymers - chemistry | Aged
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.